CAD and colorectal carcinoma: We found that the mRNA levels of CAD, as determined by the real-time quantitative PCR (RT-PCR) analysis, remained unchanged in GC and CRC cells after the treatments of chemotherapy drugs (Supplementary Fig. 2a), excluding the possibility that chemotherapy drugs downregulate CAD through the suppression of CAD expression.